DuPont (NYSE: DD) is a global materials science company that provides technology-based products and solutions. It operates in key sectors like electronics, water, and industrial technologies. The company has a market capitalization of approximately $19.78 billion. DuPont shares currently trade at $48.26, near the top of their 52-week range of $27.45 to $52.66.
An analyst at Goldman Sachs, Joe Ritchie, sets a price target of $53.00 for DuPont. This target suggests a potential increase of 9.82% from its current trading price. Such targets are estimates of a stock's future value, giving investors an idea of its perceived growth potential based on analyst research and stock forecast.
Recent company developments support this positive outlook. As highlighted by PR Newswire, DuPont's U.S. healthcare manufacturing sites now run on 100 percent renewable electricity. This move covers 12 facilities and is a key step toward its goal of achieving net-zero carbon emissions by 2050, which can attract environmentally-focused investors and enhance its ESG profile.
Furthermore, DuPont secures a significant contract in Australia. Its MemCor™ membrane bioreactor system is selected for a major upgrade at the Riverstone Water Resource Recovery Facility in Sydney. This project shows strong demand for DuPont's water solutions and its role in large-scale infrastructure investments.
The project involves supplying 2,592 MemPulse B50 MBR modules to handle the region's growing population. The upgraded plant is designed for an average daily flow of 24.8 megaliters. This demonstrates the scale of DuPont's technology and its application in critical environmental and community projects.
